Splenomegaly: Difference between revisions
Iqra Qamar (talk | contribs) No edit summary |
Iqra Qamar (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
{{SK}} Spleen enlargement; enlarged spleen; spleen swelling | {{SK}} Spleen enlargement; enlarged spleen; spleen swelling | ||
== | ==Overview | ||
== | ==Historical Perspective== | ||
== | ==Classification== | ||
== | ==Pathophysiology== | ||
== | ==Causes== | ||
== | ==Differentiating Splenomegaly from Other Diseases== | ||
== | ==Epidemiology and Demographics== | ||
== | ==Risk Factors== | ||
== | ==Screening== | ||
== | ==Natural History, Complications, and Prognosis== | ||
==Diagnosis== | |||
== Treatment == | == Treatment == | ||
== Case Studies == | == Case Studies == |
Revision as of 00:48, 17 September 2018
WikiDoc Resources for Splenomegaly |
Articles |
---|
Most recent articles on Splenomegaly Most cited articles on Splenomegaly |
Media |
Powerpoint slides on Splenomegaly |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Splenomegaly at Clinical Trials.gov Clinical Trials on Splenomegaly at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Splenomegaly
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Splenomegaly Discussion groups on Splenomegaly Patient Handouts on Splenomegaly Directions to Hospitals Treating Splenomegaly Risk calculators and risk factors for Splenomegaly
|
Healthcare Provider Resources |
Causes & Risk Factors for Splenomegaly |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Gichoya Judy Wawira [2], Moi University School of Medicine
Synonyms and keywords: Spleen enlargement; enlarged spleen; spleen swelling
==Overview